Mouse transient receptor potential channel type 6 selectively regulates agonist-induced platelet function.

Area of Science:

• Cardiovascular Biology
• Molecular Physiology
• Hematology

Background:

• Intracellular calcium is key to platelet activation and thrombus formation.
• The role of receptor-operated calcium entry (ROCE) via transient receptor potential channels (TRPCs) in platelets is not well understood.
• Previous work indicated TRPC6 influences hemostasis and thrombosis in mice.

Purpose of the Study:

• To investigate the specific role and mechanism of TRPC6 in ROCE and platelet activation.
• To characterize TRPC6 function in a knockout mouse model.

Main Methods:

• Utilized a Trpc6 knockout mouse model.
• Assessed intracellular calcium levels and ROCE in platelets.
• Evaluated platelet aggregation, granule secretion, and integrin αIIbβ3 activation.
• Tested responses to thromboxane receptor (TPR) agonists, ADP, and TRAP4.
• Examined clot retraction.

Main Results:

• Trpc6 knockout platelets showed impaired intracellular calcium elevation and ROCE.
• These platelets exhibited defects in aggregation, secretion, and integrin αIIbβ3 activation.
• Defects were specific to TPR activation, not ADP or TRAP4.
• TRPC6 was found to regulate clot retraction.
• OAG stimulation also revealed ROCE defects in Trpc6 knockout platelets.

Conclusions:

• TRPC6 directly regulates TPR-dependent ROCE and platelet function.
• TRPC6 plays a significant role in platelet activation and thrombus formation.
• TRPC6 represents a potential therapeutic target for thrombotic diseases.